Location History:
- Munchen, DE (2000)
- München, DE (2001 - 2009)
- Munich, DE (1998 - 2020)
Company Filing History:
7 out of 7 
5 out of 480 
1 out of 1 Years Active: 1998-2020
Title: The Innovative Contributions of Inventor Manfred Motz
Introduction: Manfred Motz, a renowned inventor based in Munich, Germany, has made significant strides in the field of biotechnology. With a prolific history of 16 patents, Motz's work focuses on developing innovative solutions for tumor therapy and viral diagnostics.
Latest Patents: Among his recent patents, two stand out for their potential impact in medical technology. The first, titled "Antigen-binding constructs that bind to and inhibit catalase and/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapy," relates to single domain VHH fragments specifically designed to bind and inhibit superoxide dismutase and catalase. This invention is particularly relevant for the therapy of tumor diseases. The second patent, "Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof," addresses virus diagnosis, specifically for Epstein-Barr virus (EBV). It involves methods for detecting EBV and introduces peptides derived from p18-VCA, enabling the differentiation between acute and past EBV infections.
Career Highlights: Motz has built a distinguished career and has worked with prominent companies, including Roche Diagnostics GmbH and Mikrogen Molekularbiologische Entwicklungs-GmbH. His expertise and innovation have played a vital role in advancing the development of diagnostic and therapeutic solutions in his field.
Collaborations: Throughout his career, Manfred Motz has collaborated with notable individuals, including Erwin Soutschek and Erwin Soutscheck. These partnerships have fostered an environment of collaboration, enhancing the innovation process and resulting in groundbreaking advancements in biotechnology.
Conclusion: Manfred Motz's contributions to the field of biotechnology through his patents exemplify the importance of innovation in addressing critical medical challenges. His work not only demonstrates the potential for significant advancements in tumor therapy and virus diagnostics but also highlights the vital role of collaboration in the success of scientific innovation.